寻常痤疮

Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol. 2003;49:S1-S37.

• 摘要

British Association of Dermatologists. Advice on the safe introduction and continued use of isotretinoin in acne in the UK 2010. March 2010. http://www.bad.org.uk (last accessed 18 August 2016).

• 全文

1.  Koo J. The psychosocial impact of acne: patient's perceptions. J Am Acad Dermatol. 1995;32:S26-S30.

• 摘要

2.  Burke BM, Cunliffe WJ. The assessment of acne vulgaris - the Leeds technique. Br J Dermatol. 1984;111:83-92.

• 摘要

3.  Jansen T, Plewig G. Acne fulminans. Int J Dermatol. 1998;37:254-257.

• 摘要

4.  Mills OH, Kligman A. Acne mechanica. Arch Dermatol. 1975;111:481-483.

• 摘要

5.  White GM. Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris. J Am Acad Dermatol. 1998;39(2 Pt 3):S34-S37.

• 摘要

6.  Wilkins JW, Voorhees JJ. Prevalence of nodulocystic acne in white and Negro males. Arch Dermatol. 1970;102:631-634.

• 摘要

7.  Cordain L, Lindeberg S, Hurtado M, et al. Acne vulgaris: a disease of western civilization. Arch Dermatol. 2002;138:1584-1590.

• 摘要

8.  Gollnick HP, Zouboulis CC, Akamatsu H. Pathogenesis and pathogenesis related treatment of acne. J Dermatol. 1991;18:489-499.

• 摘要

9.  Cunliffe WJ, Holland DB, Clark SM, et al. Comedogenesis: some new aetiological, clinical, and therapeutic strategies. Dermatology. 2003;206:11-16.

• 摘要

10.  Leyden JJ, McGinley KJ, Mills OH, et al. Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol. 1975;65:382-384.

• 摘要

11.  Walton S, Wyatt EH, Cunliffe WJ. Genetic control of sebum excretion in acne - a twin study. Br J Dermatol. 1988;118:393-396.

• 摘要

12.  Bataille V, Snieder H, MacGregor AJ, et al. The influence of genetics and environmental factors in the pathogenesis of acne: a twin study of acne in women. J Invest Dermatol. 2002;119:1317-1322.

• 摘要

13.  Knutson DD. Ultrastructural observations in acne vulgaris: the normal sebaceous follicle and acne lesions. J Invest Dermatol. 1974;62:288-307.

• 摘要

14.  Scott DG, Cunliffe WJ, Gowland G. Activation of complement - a mechanism for the inflammation in acne. Br J Dermatol. 1979;101:315-320.

• 摘要

15.  Anderson PC. Foods as the cause of acne. Am Fam Physician. 1971;3:102-103.

• 摘要

16.  Grant JD, Anderson PC. Chocolate and acne: a dissenting view. Mo Med. 1965;62:459-460.

• 摘要

17.  Thiboutot DM, Strauss JS. Diet and acne revisited. Arch Dermatol. 2002;138:1591-1592.

• 摘要

18.  Strauss JS, Pochi PE. Effect of cyclic progestin-estrogen therapy on sebum and acne in women. JAMA. 1964;190:815-819.

• 摘要

19.  Aizawa H, Niimura M. Elevated serum insulin-like growth factor-1 (IGF-1) levels in women with postadolescent acne. J Dermatol. 1995;22:249-252.

• 摘要

20.  Bourne S, Jacobs A. Observations on acne, seborrhea, and obesity. Br Med J. 1956;1:1268-1270.

• 摘要

21.  Brown SK, Shalita AR. Acne vulgaris. Lancet. 1998;351:1871-1876.

• 摘要

22.  Hull PR, D'Arcy C. Acne, depression, and suicide. Dermatol Clin. 2005;23:665-674.

• 摘要

23.  Khumalo NP, Jessop S, Ehrlich R. Prevalence of cutaneous adverse effects of hairdressing. Arch Dermatol. 2006;142:377-383.

• 摘要

24.  Rosas Vazquez E, Campos Macias P, Ochoa Tirado JG, et al. Chloracne in the 1990s. Int J Dermatol. 1996;35:643-645.

• 摘要

25.  Lewis KG, Bercovitch L, Dill SW, et al. Acquired disorders of elastic tissue: Part I. increased elastic tissue and solar elasotic syndromes. J Am Acad Dermatol. 2004;51:1-21.

• 摘要

26.  Sehgal VN, Srivastava G, Aggarwal AK, et al. Lupus miliaris disseminatus faciei part II: an overview. Skinmed. 2005;4:234-238.

• 摘要

27.  Hengge UR, Ruzicka T, Schwartz RA, et al. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54:1-15.

• 摘要

28.  Plewig G, Jansen T, Kligman AM. Pyoderma faciale. A review and report of 20 additional cases: is it rosacea? Arch Dermatol. 1992;128:1611-1617.

• 摘要

29.  Schwartz RA, Fernandez G, Kotulska K, et al. Tuberous sclerosis complex: advances in diagnosis, genetics, and management. J Am Acad Dermatol. 2007;57:189-202.

• 摘要

30.  US Food and Drug Administration. Acne vulgaris: developing drugs for treatment. September 2005. http://www.fda.gov (last accessed 18 August 2016).

• 全文

31.  Kawashima M, Harada S, Loesche C, et al. Adapalene gel 0.1% is effective and safe for Japanese patients with acne vulgaris: a randomized, multicenter, investigator-blinded, controlled study. J Dermatol Sci. 2008;49:241-248.

• 摘要

32.  Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol. 2003;49:S1-S37.

• 摘要

33.  Shalita AR. Treatment of mild and moderate acne vulgaris with salicylic acid in an alcohol-detergent vehicle. Cutis. 1981;28:556-558;561.

• 摘要

34.  Seidler EM, Kimball AB. Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne. J Am Acad Dermatol. 2010;63:52-62.

• 摘要

35.  Jackson JM, Fu JJ, Almekinder JL. A randomized, investigator-blinded trial to assess the antimicrobial efficacy of a benzoyl peroxide 5%/ clindamycin phosphate 1% gel compared with a clindamycin phosphate 1.2%/tretinoin 0.025% gel in the topical treatment of acne vulgaris. J Drugs Dermatol. 2010;9:131-136.

• 摘要

36.  Thiboutot DM, Weiss J, Bucko A, et al; Adapalene-BPO Study Group. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study. J Am Acad Dermatol. 2007;57:791-799.

• 摘要

37.  Gollnick HP, Draelos Z, Glenn MJ. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: A transatlantic, randomized, double-blind, controlled study in 1670 patients. Br J Dermatol. 2009;161:1180-1189.

• 摘要

38.  Poulin YS, Sanchez NP, Bucko A, et al. A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial. Br J Dermatol. 2011;164:1376-1382.

• 摘要

39.  Graupe K, Cunliffe W, Gollnick H, et al. Efficacy and safety of topical azelaic acid (20% cream): an overview of results from European clinical trials and experimental reports. Cutis. 1996;57:20-35.

• 摘要

40.  Ochsendorf F. Systemic antibiotic therapy of acne vulgaris [in German]. J Dtsch Dermatol Ges. 2010;8(suppl 1):S31-S46.

• 摘要

41.  Zouboulis CC, Rabe T. Hormonal antiandrogens in acne treatment [in German]. J Dtsch Dermatol Ges. 2010;8(suppl 1):S60-S74.

• 摘要

42.  Arowojolu AO, Gallo MF, Lopez LM, et al. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. 2012;(7):CD004425.

• 全文
• 摘要

43.  Cunliffe WJ, Poncet M, Loesche C, et al. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials. Br J Dermatol. 1998;139(suppl 52):48-56.

• 摘要

44.  Zouboulis CC, Piquero-Martin J. Update and future of systemic acne treatment. Dermatology. 2003;206:37-53.

• 摘要

45.  Simonart T, Dramaix M, De Maertelaer V. Efficacy of tetracyclines in the treatment of acne vulgaris: a review. Br J Dermatol. 2008;158:208-216.

• 摘要

46.  Goldsmith LA, Bolognia JL, Callen JP, et al; American Academy of Dermatology. American Academy of Dermatology Consensus Conference on the safe and optimal use of isotretinoin: summary and recommendations. J Am Acad Dermatol. 2004;50:900-906.

• 摘要

47.  British Association of Dermatologists. Advice on the safe introduction and continued use of isotretinoin in acne in the UK 2010. March 2010. http://www.bad.org.uk (last accessed 18 August 2016).

• 全文

48.  Reddy D, Siegel CA, Sands BE, et al. Possible association between isotretinoin and inflammatory bowel disease. Am J Gastroenterol. 2006;101:1569-1573.

• 摘要

49.  Bernstein CN, Nugent Z, Longobardi T, et al. Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study. Am J Gastroenterol. 2009;104:2774-2778.

• 摘要

50.  Racine A, Cuerq A, Bijon A, et al. Isotretinoin and risk of inflammatory bowel disease: a French nationwide study. Am J Gastroenterol. 2014;109:563-569.

• 摘要

51.  Muhlemann MF, Carter GD, Cream JJ, et al. Oral spironolactone: an effective treatment for acne vulgaris in women. Br J Dermatol. 1986;115:227-232.

• 摘要

52.  Tzung TY, Wu KH, Huang ML. Blue light phototherapy in the treatment of acne. Photodermatol Photoimmunol Photomed. 2004;20:266-269.

• 摘要

53.  Kawada A, Aragane Y, Kameyama H, et al. Acne phototherapy with a high-intensity, enhanced, narrow-band, blue light source: an open study and in vitro investigation. J Dermatol Sci. 2002;30:129-135.

• 摘要

54.  Riddle CC, Terrell SN, Menser MB, et al. A review of photodynamic therapy (PDT) for the treatment of acne vulgaris. J Drugs Dermatol. 2009;8:1010-1019.

• 摘要

55.  Seaton E, Charakida A, Mouser P, et al. Pulsed-dye laser treatment for inflammatory acne vulgaris: randomized controlled trial. Lancet. 2003;362:1347-1352.

• 摘要

56.  Orringer JS, Kang S, Hamilton T, et al. Treatment of acne vulgaris with a pulsed dye laser: a randomized controlled trial. JAMA. 2004;291:2834-2839.

• 摘要

57.  Haedersdal M, Togsverd-Bo K, Wulf HC. Evidence-based review of lasers, light sources and photodynamic therapy in the treatment of acne vulgaris. J Eur Acad Dermatol Venereol. 2008;22:267-278.

• 摘要

58.  Hamilton FL, Car J, Lyons C, et al. Laser and other light therapies for the treatment of acne vulgaris: systematic review. Br J Dermatol. 2009;160:1273-1285.

• 摘要

59.  Ong MW, Bashir SJ. Fractional laser resurfacing for acne scars: a review. Br J Dermatol. 2012;166:1160-1169.

• 摘要